Clinical Trials Browser

Interventional × Prostate Adenocarcinoma × Docetaxel × Clear all

NCT00183924 2014-05-22

Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.

Phase 2 Completed

Prostate Adenocarcinoma